Notice of Intent to Sole Source-Olympus BX53F2 and BX43 Microscopic Systems
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), Clinical Center, Department of Laboratory Medicine has issued a Notice of Intent to Sole Source for the procurement and installation of Olympus BX53F2 and BX43 clinical microscopy systems and associated components. The NIH intends to award a firm-fixed-price purchase order to Evident Scientific MIS, Inc. for these systems, which are crucial for supporting Hematology diagnostic operations. Capability statements from interested parties are due by May 30, 2026.
Scope of Requirement
The requirement includes:
- Two (2) Olympus BX53F2 Dual Observation Microscopes with DP75 Cameras
- Two (2) Cellsens software licenses
- Three (3) Olympus BX43 Microscopes
- One (1) DP23 Camera with dual observation attachment
- Associated Cellsens software licenses and accessories
These systems are needed to improve diagnostic accuracy, workflow efficiency, staff safety, and laboratory compliance within the Hematology Service. They will provide enhanced brightfield visualization, support real-time case sharing, communication with care teams, backup imaging, and SoftPath image integration.
Sole Source Justification
Evident Scientific MIS, Inc. is identified as the sole responsible source due to its unique qualification as an authorized distributor and service provider for Olympus clinical microscopy systems. They possess the demonstrated capability to provide compatible hardware, software integration, installation, warranty support, training, and ongoing technical support. Their specialized expertise in configuring microscopy systems for hematology and pathology applications, including integration with existing Cellsens imaging software and SoftPath reporting workflows, is critical.
Submission Information
This notice is not a request for competitive quotations. However, responsible sources may submit capability statements to demonstrate their ability to provide the required Olympus microscopy systems, integrated software compatibility, installation, warranty support, and related technical services. Submissions must include "26-005825" in the email subject.
Contract & Timeline
- Type: Notice of Intent to Sole Source (Firm-Fixed-Price Purchase Order)
- Set-Aside: None (Sole Source)
- Response Due: May 30, 2026, at 4:30 PM EST
- Published: May 20, 2026
- Contracting Office: NIH, Office of Acquisition and Logistics Management
Additional Notes
A determination by the Government not to compete this proposed acquisition based on responses to this notice is solely within the Government's discretion.